435 related articles for article (PubMed ID: 29019150)
1. The Zollinger-Ellison syndrome: is there a role for somatostatin analogues in the treatment of the gastrinoma?
Guarnotta V; Martini C; Davì MV; Pizza G; Colao A; Faggiano A;
Endocrine; 2018 Apr; 60(1):15-27. PubMed ID: 29019150
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin analogs in patients with Zollinger Ellison syndrome (ZES): an observational study.
Massironi S; Cavalcoli F; Elvevi A; Quatrini M; Invernizzi P
Endocrine; 2022 Mar; 75(3):942-948. PubMed ID: 34716542
[TBL] [Abstract][Full Text] [Related]
3. Medical treatment of gastrinomas.
Auernhammer CJ; Göke B
Wien Klin Wochenschr; 2007; 119(19-20):609-15. PubMed ID: 17985097
[TBL] [Abstract][Full Text] [Related]
4. Sporadic and MEN1-related gastrinoma and Zollinger-Ellison syndrome: differences in clinical characteristics and survival outcomes.
Massironi S; Rossi RE; Laffusa A; Eller-Vainicher C; Cavalcoli F; Zilli A; Ciafardini C; Sciola V; Invernizzi P; Peracchi M
J Endocrinol Invest; 2023 May; 46(5):957-965. PubMed ID: 36436191
[TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy of Zollinger-Ellison syndrome.
Ito T; Igarashi H; Uehara H; Jensen RT
Expert Opin Pharmacother; 2013 Feb; 14(3):307-21. PubMed ID: 23363383
[TBL] [Abstract][Full Text] [Related]
6. Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies.
Rossi RE; Elvevi A; Citterio D; Coppa J; Invernizzi P; Mazzaferro V; Massironi S
World J Gastroenterol; 2021 Sep; 27(35):5890-5907. PubMed ID: 34629807
[TBL] [Abstract][Full Text] [Related]
7. Treatment of neuroendocrine GEP tumours with somatostatin analogues: a review.
Arnold R; Simon B; Wied M
Digestion; 2000; 62 Suppl 1():84-91. PubMed ID: 10940693
[TBL] [Abstract][Full Text] [Related]
8. Classical features of Zollinger-Ellison syndrome, in images.
Alshati A; Kachaamy T
Gastrointest Endosc; 2019 Jun; 89(6):1255-1257. PubMed ID: 30735650
[No Abstract] [Full Text] [Related]
9. Optimal treatment of Zollinger-Ellison syndrome and related conditions in elderly patients.
Tomassetti P; Salomone T; Migliori M; Campana D; Corinaldesi R
Drugs Aging; 2003; 20(14):1019-34. PubMed ID: 14651442
[TBL] [Abstract][Full Text] [Related]
10. Regression of a large malignant gastrinoma on treatment with Sandostatin LAR: a case report.
Granberg D; Jacobsson H; Oberg K; Gustavsson J; Lehtihet M
Digestion; 2008; 77(2):92-5. PubMed ID: 18376130
[TBL] [Abstract][Full Text] [Related]
11. Case report: optimal tumor cytoreduction and octreotide with durable disease control in a patient with MEN-1 and Zollinger-Ellison syndrome-over a decade of follow-up.
Daniels LM; Khalili M; Morano WF; Simoncini M; Mapow BC; Leaf A; Bowne WB
World J Surg Oncol; 2019 Dec; 17(1):213. PubMed ID: 31818296
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of gastrinoma in the era of proton pump inhibitors.
Banasch M; Schmitz F
Wien Klin Wochenschr; 2007; 119(19-20):573-8. PubMed ID: 17985090
[TBL] [Abstract][Full Text] [Related]
13. How to treat gastrinomas in patients with multiple endocrine neoplasia type1: surgery or long-term proton pump inhibitors?
Imamura M; Komoto I; Taki Y
Surg Today; 2023 Dec; 53(12):1325-1334. PubMed ID: 36473964
[TBL] [Abstract][Full Text] [Related]
14. Zollinger-Ellison syndrome. Diagnosis and therapy.
Campana D; Piscitelli L; Mazzotta E; Bonora M; Serra C; Salomone L; Corinaldesi R; Tomassetti P
Minerva Med; 2005 Jun; 96(3):187-206. PubMed ID: 16175161
[TBL] [Abstract][Full Text] [Related]
15. Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome.
Alexander HR; Fraker DL; Norton JA; Bartlett DL; Tio L; Benjamin SB; Doppman JL; Goebel SU; Serrano J; Gibril F; Jensen RT
Ann Surg; 1998 Aug; 228(2):228-38. PubMed ID: 9712569
[TBL] [Abstract][Full Text] [Related]
16. The new concept of therapeutic strategy for neuroendocrine tumors: important information from a case report of gastrinoma.
Igarashi H; Ito T; Takayanagi R
Intern Med; 2010; 49(17):1839-40. PubMed ID: 20823641
[No Abstract] [Full Text] [Related]
17. Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features.
Anlauf M; Garbrecht N; Henopp T; Schmitt A; Schlenger R; Raffel A; Krausch M; Gimm O; Eisenberger CF; Knoefel WT; Dralle H; Komminoth P; Heitz PU; Perren A; Klöppel G
World J Gastroenterol; 2006 Sep; 12(34):5440-6. PubMed ID: 17006979
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future.
Stueven AK; Kayser A; Wetz C; Amthauer H; Wree A; Tacke F; Wiedenmann B; Roderburg C; Jann H
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234481
[TBL] [Abstract][Full Text] [Related]
19. Gastrinomas: Medical or Surgical Treatment.
Norton JA; Foster DS; Ito T; Jensen RT
Endocrinol Metab Clin North Am; 2018 Sep; 47(3):577-601. PubMed ID: 30098717
[TBL] [Abstract][Full Text] [Related]
20. Zollinger-Ellison syndrome in 2006: concepts from a clinical point of view.
Pellicano R; De Angelis C; Resegotti A; Rizzetto M
Panminerva Med; 2006 Mar; 48(1):33-40. PubMed ID: 16633330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
